Cyclerion Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	8	8	29	75	104	75
Market Cap Growth	-	-71.30%	-61.69%	-28.31%	39.09%	-
Enterprise Value	1	1	15	21	95	54
PE Ratio	-1.56	-1.56	-0.65	-1.44	-1.34	-0.61
PS Ratio	-	-	96.10	18.90	45.26	16.58
PB Ratio	0.73	0.73	2.73	1.54	1.75	0.77
P/FCF Ratio	-0.39	-0.39	-0.70	-2.13	-1.43	-0.69
P/OCF Ratio	-0.39	-0.39	-0.70	-2.04	-1.43	-0.73
EV/Sales Ratio	-	-	51.04	5.21	41.49	11.92
EV/EBITDA Ratio	-0.11	-0.11	-0.34	-0.40	-1.25	-0.44
EV/EBIT Ratio	-0.11	-0.11	-0.34	-0.40	-1.22	-0.43
EV/FCF Ratio	-0.03	-0.03	-0.37	-0.59	-1.31	-0.49
Debt / Equity Ratio	-	-	-	-	0.77	0.76
Debt / EBITDA Ratio	-	-	-	-	-0.60	-0.60
Debt / FCF Ratio	-	-	-	-	-0.63	-0.68
Quick Ratio	3.63	3.63	1.77	4.88	3.22	5.28
Current Ratio	3.85	3.85	1.94	5.00	3.45	5.55
Asset Turnover	0	0	0.01	0.05	0.02	0.03
Interest Coverage	-	-	-	-3226.94	-	-
Return on Equity (ROE)	-63.30%	-63.30%	-197.30%	-94.60%	-110.20%	-140.40%
Return on Assets (ROA)	-42.00%	-42.00%	-141.20%	-68.20%	-60.40%	-76.70%
Return on Capital (ROIC)	-114.73%	-114.73%	-177.38%	-114.40%	-77.23%	-72.84%
Earnings Yield	-63.88%	-64.25%	-154.44%	-69.32%	-74.86%	-164.64%
FCF Yield	-257.87%	-259.37%	-142.29%	-47.06%	-69.74%	-145.79%
Buyback Yield / Dilution	-7.59%	-7.59%	-0.33%	-27.54%	-23.64%	-76.59%
Total Shareholder Return	-7.59%	-7.59%	-0.33%	-27.54%	-23.64%	-76.59%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).